INTRODUCTION
Zymosan is a boiled, trypsin-treated cell wall preparation of Saccharomyces cerevisiae that has been used for over 50 years as a model microbial particle in studies on innate immune responses including stimulation of inflammatory cytokine and chemokine production, mechanisms of phagocytosis, and activation of complement deposition. [1] [2] [3] Zymosan has been so widely used because it fulfils the experimental requirement for a model of a microbial particle; it is easily prepared, consistent between preparations, and (unlike the surface of a live microbe) composed of a limited number of defined components. Yeast cell walls are composed primarily of a b1,3-glucan core (greater that half the cell wall weight) linked to chitin and b1,6-glucans. 4 A small group of highly mannosylated cell wall proteins are linked to the wall through GPI anchors to b1,6-glucan and by direct conjugation to b1,3-glucan reducing ends. 5 Phagocytes including monocytes, macrophages, and dendritic cells express a variety of receptors including the mannose receptor, complement receptors, and b-glucan receptors that have been demonstrated to play roles in recognition and internalisation of zymosan particles. 3, [6] [7] [8] Thus, phagocytosis of zymosan is mediated by a repertoire of different receptors that recognize the same and different components of the particle and mediate internalisation. Deficiency in any one of these recognition systems has little or no effect on zymosan internalisation. 6 In contrast to zymosan phagocytosis, inflammatory responses to zymosan depend largely on a single receptor, a heterodimer of Toll-like receptors TLR2 and TLR6. 9,10 Tolllike receptor family members mediate recognition and inflammatory responses to a wide range of microbial products and are required for effective host defence. 11 We have previously demonstrated that phagocytosis of zymosan is accompanied by the recruitment of TLR2 and TLR6 to the phagosome and that activation of a TLR2/TLR6 heterodimer by zymosan is required for inflammatory responses such as the production of TNF-a and activation of NF-kB. 10, 12 Toll-like receptor activation is not required for particle binding or internalisation since inhibition of TLR2, or MyD88 (an adapter molecule required for TLR signalling) by expression of dominant negative proteins blocks pro-inflammatory signalling, but does not alter particle uptake. 10 Further evidence for the functional separation of phagocytosis from inflammatory signalling in response to zymosan has come from studies blocking phagocytosis; inhibition of phagocytosis by expression of an inhibitory form of dynamin or by treatment with pharmacological inhibitors of PI-3 kinase does not block activation of TNFa production by zymosan. 13 Thus, TLRs mediate inflammatory responses to zymosan and additional innate immune recognition receptors mediate phagocytosis.
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Despite the fact that phagocytosis and inflammatory signalling can be experimentally uncoupled, the fact that these processes occur simultaneously, in close proximity to each other, and utilize many of the same intracellular signalling components suggests that significant cross-talk may occur. 6 Since zymosan particles contain pathogen-associated molecular patterns (PAMPS) 14 that are recognized by innate immune recognition receptors involved in phagocytosis and by additional innate immune recognition receptors involved in inflammatory signalling, zymosan is a perfect model particle for studying in detail the interactions between phagocytic and inflammatory signalling receptors. In support of our on-going studies in this area, we have further characterized inflammatory responses to zymosan in a murine macrophage cell line. First, we have examined the requirement for particulate recognition (versus potential recognition of a soluble component of the preparation) and examined the capacity for a single particle to activate inflammatory responses. Second, we have explored whether phagocytic receptors for zymosan require recognition of the same molecular pattern seen by TLR2/TLR6.
MATERIALS AND METHODS
Zymosan preparation
Zymosan (Molecular Probes and Sigma) was resuspended to 10 mg/ml in sterile PBS, sonicated for 15 min, boiled for 15 min, and pelleted by centrifugation. The procedure was repeated four more times to prepare the stock solution of zymosan. The preparation contained no detectable LPS as measured by the Limulus assay (BioWhittaker), and inclusion of polymyxin B had no effect on the stimulatory activity of the preparation (data not shown). Particle concentration was determined by counting on a haemocytometer. For hot alkali treatment, zymosan prepared as above was resuspended in 10 N NaOH, boiled for 1 h, and washed 5 times with PBS. For extraction, zymosan was resuspended in chloroform/methanol/water (10:10:3), sonicated for 30 min, washed once with chloroform/methanol/ water, and washed 3 times with PBS.
Luciferase assays
Preparation of the stable population of RAW264.7 cells transfected with an NF-kB reporter plasmid (ELAMluciferase) has been previously reported. 15 Cells were plated into a 96-well plate or a Transwell plate (Costar) and used when 50-70% confluent. Cells were stimulated with the indicated concentrations of zymosan for 4 h, and firefly luciferase activity was measured using the Luciferase Assay System (Promega) according to the manufacturer's instructions.
Intracellular cytokine detection
RAW 264.7 cells were stimulated with FITC-labelled zymosan in the presence of 5 mg/ml brefeldin A. Extracellular particles were removed first by washing with PBS and then by incubating for 15 min in PBS with 1 mM EDTA, 1 mM sodium azide, and 100 U/ml lyticase (Sigma) to dissolve extracellular particles. The cells were fixed and stained for intracellular TNF-a with a PE-conjugated anti-TNF-a antibody (Pharmingen) as previously described. 10 Cells were analysed by flow cytometry, and TNF-a production was compared in cells eating particles (FITC-positive) versus neighbouring cells not eating particles (FITC-negative). Data were analysed using WinMDI software (J. Trotter, Scripps).
Microscopy
RAW 264.7 cells were incubated with the indicated zymosan particles for 15 min, washed with media, and further incubated for 15 min in media containing 100 U/ml lyticase (Sigma) to fully remove extracellular particles. The cells were fixed, mounted and imaged on a Leica TCS SP2 confocal microscope. The number of particles internalised by greater than 300 cells/coverslip was recorded, and phagocytic index was calculated as the number of particles internalised/100 cells.
RESULTS AND DISCUSSION
The mouse macrophage cell line, RAW264.7, stably transfected with an NF-kB luciferase reporter plasmid (RAW-NF-kB) responds to as little as 1 ng/ml lipopolysaccharide (a TLR4 stimulus) or PAM 3 CSK 4 lipopeptide (a TLR2 stimulus) making these cells a highly sensitive tool for assessing TLR activation. 15 When RAW-NF-kB cells were stimulated with zymosan particles, maximal activation occurred at 100 mg/ml, and NF-kB activation could not be detected at less than 5 mg/ml (Fig. 1A) . The data suggested either that zymosan detection is highly inefficient compared to stimuli such as LPS or PAM 3 CSK 4 lipopeptide or that direct particle contact is required for activation (particles become limiting at lower doses). We calculated the ratio of zymosan particles to macrophages required to activate the response, and we observed that maximal activation occurred at approximately 1 zymosan particle per macrophage (Fig.  1A) . To be certain that zymosan-induced macrophage activation was truly contact-dependent and that the zymosan preparation did not simply contain small amounts of soluble stimuli, we stimulated RAW-NF-kB cells in Transwells. Zymosan (200 mg/ml) was stimulatory when added to the bottom of the Transwell, but had very little activity when added to the top, while soluble PAM 3 CSK 4 lipopeptide was fully stimulatory when added to the top chamber (Fig. 1B) . The data demonstrate that direct particle contact is required for zymosan activation of macrophages.
We next examined whether contact with a single particle is sufficient to trigger cytokine production in a macrophage. We stimulated RAW cells with fluorescently labelled zymosan at a low particle:cell ratio such that only 10% of the cells internalised a particle. This procedure ensured that the vast majority of macrophages internalising zymosan ate only a single particle. Production of TNFa was then measured by flow cytometry. Cells that ate zymosan produced copious amounts of TNF-a while cells in the same well that failed to eat particles did not produce the cytokine (Fig. 1C) . Thus, phagocytosis of a single particle is sufficient to trigger inflammatory responses.
We have previously demonstrated that inhibition of TLR signalling through expression of dominant negative forms of TLR2 or MyD88 (an adapter molecule required for TLR signalling) does not alter internalisation of zymosan; 10 thus, signalling through receptors other than TLRs triggers internalisation. Additionally, we have demonstrated that internalisation of zymosan by these additional receptors is not required to trigger responses through TLRs. 13 Thus, blocking internalisation by expression of a dominant negative form of dynamin or by pharmacological inhibition of PI-3 kinase does not inhibit production of TNF-a in response to zymosan. 13 To extend this set of observations, the question of whether blocking zymosan recognition by TLRs would have any effect on internalisation of the particles was examined.
A variety of methods for ablating the TLR-stimulating activity in zymosan were explored. Hot alkaline lysis completely destroyed the ability of zymosan particles to activate NF-kB ( Fig. 2A) , although the particles were still recognized and internalised by macrophages within 15 min (Fig. 2B ). Internalisation was slightly less efficient than for untreated particles (phagocytic index control zymosan, 49 ± 2, alkali-treated zymosan 23 ± 3, P < 0.01). Thus, innate immune recognition receptors other than TLRs recognize ligands distinct from the one recognized by TLR2 and deliver intracellular signals sufficient to mediate the reorganization of the actin cytoskeleton and membrane recruitment required for phagocytosis. Interestingly, extraction of the zymosan preparation with chloroform/methanol/water also removed the stimulatory such that only 10% of the cells internalised a particle. Production of TNF-a was measured by intracellular cytokine staining (inset). In the histogram, the thin black line represents TNF-a production by cells not internalising particles (FITC-negative), while the thick black line represents macrophages that ate a particle (FITC-positive). The dotted line represents control unstimulated cells. All experiments were performed at least 3 times. activity ( Fig. 2A ), suggesting that the TLR ligand in zymosan is associated with, but not covalently bound to, the cell wall. The TLR ligand solubility in chloroform/ methanol/water, but not in water, suggests that it is a yeastderived lipid or lipid-modified molecule. Further studies will be required to definitively identify this molecule. Removal of the TLR-stimulating activity from zymosan did not inhibit the ability of macrophages to internalise the particles (Fig. 2B ; phagocytic index 54 ± 11), indicating that the ligand recognized by macrophage phagocytic receptors is not extractable. There were no consistent morphological differences between cells internalising different particles. We have previously observed that activation of NF-kB by zymosan is blocked by inhibition of TLR2, and the current data provide an independent confirmation of the conclusion that ingestion of particles through innate phagocytic receptors is not necessarily sufficient to trigger activation of NF-kB.
The fact that TLRs detect soluble stimuli such as LPS and PAM 3 CSK 4 lipopeptide with high sensitivity, while zymosan is detected with much lower sensitivity is explained by the fact that zymosan contact is required for inflammatory stimulation and that the TLR-activating component is a minor constituent in the complex particle. The data suggest that phagocytic receptor recognition of surface components of microbes may facilitate simultaneous or subsequent recognition of additional components by TLRs, a theme that will require further studies to verify. 
